Original Articles

How Much Digital Rectal Examination is Valuable for the Decision of Biopsy in Patients with PSA ≤4 ng/ml?
  • Özgü Aydoğdu
  • İbrahim Halil Bozkurt
  • Tarık Yonguç
  • Tansu Değirmenci
  • Salih Polat
  • Bülent Günlüsoy
  • İbrahim Küçüktürkmen
  • Yasin Ceylan
  • Süleyman Minareci
Bull Urooncol 2015; 14: 1-4 DOI: 10.4274/uob.253
Is Prostate Specific Antigen Density more Important than in the Diagnosis of Prostate Cancer in Patients with a Total Prostate Specific Antigen Value <10 ng/mL?
  • Soner Çoban
  • Muhammet Güzelsoy
  • Ali Rıza Türkoğlu
  • Ünal Kurtoğlu
  • Dursun Ünal
  • Noyan Can Akdur
  • Sedat Öner
  • Murat Demirbaş
Bull Urooncol 2015; 14: 83-87 DOI: 10.4274/uob.268
Role of Prostate Specific Antigen Density for the Prediction of Radical Therapy Requirement in Localized Prostate Cancer
  • Ozan Bozkurt
  • Kaan Çömez
  • Özgür Gürboğa
  • Ömer Demir
  • Güven Aslan
  • Adil Esen
Bull Urooncol 2016; 15: 103-106 DOI: 10.4274/uob.701

Review

PSA: past, today and tomorrow
  • Levent Mert Günay
  • Sertaç Yazıcı
  • Haluk Özen
Bull Urooncol 2011; 10: 5-10
Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
  • Tayyar Alp Özkan
  • Özdal Dillioğlugil
Bull Urooncol 2014; 13: 41-45
Algorithmic approach to rising PSA after curative prostate cancer treatment
  • Levent Mert Günay
  • Şevket Tolga Tombul
  • Bülent Akdoğan
Bull Urooncol 2011; 10: 51-55
Is prostate cancer be screened according to Turkey data?
  • Rahmi Gökhan Ekin
  • Ferruh Zorlu
Bull Urooncol 2013; 12: 71-75

Literature Review

  • Thomas Stamey
Bull Urooncol 2004; 3: 20-22

Article - Comment

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening
  • Sinan Ekici
Bull Urooncol 2006; 5: 27-29
  • Saadettin Yilmaz Eskiçorapçi
Bull Urooncol 2006; 5: 33-34

About Journal

Forms

Useful Links

Applications